27 reports

Global Anxiety Disorder Epidemiology and Patient Flow Analysis - 2017 ##.

  • Anxiety Disorder
  • France
  • United States
  • World
  • Forecast
  • Social Anxiety Disorders (SAD) Therapeutics, Global, Clinical Trials by Phase (%), 2016*
  • Social Anxiety Disorders (SAD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*

Social Anxiety Disorders (SAD) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Social Anxiety Disorders (SAD) Global Clinical Trials Review, H2, 2016" provides an overview of Social Anxiety Disorders (SAD) clinical trials scenario. This report provides top line data relating to the...

  • Anxiety Disorder
  • Mental Health
  • Therapy
  • World
  • Product Initiative

General Anxiety Disorder Ongoing Global Clinical Trials Analysis and Outlook ## Table of Contents ##. ## List of Figures ##. ## List of Tables ## Key Findings, 2018 ##. ## Snapshot ##. ## Overview of General Anxiety Disorder Trials ## Clinical Trials Trends to 2022 ##. ##

  • Anxiety Disorder
  • Clinical Trial
  • Drug Discovery And Development
  • Mental Health
  • Pathology

Social Anxiety Disorders (SAD) Ongoing Global Clinical Trials Analysis and Outlook ## Table of Contents ##. ## List of Figures ##. ## List of Tables ## Key Findings, 2018 ##. ## Snapshot ##. ## Overview of Social Anxiety Disorders (SAD) Trials ## Clinical Trials Trends

  • Anxiety Disorder
  • Clinical Trial
  • Drug Discovery And Development
  • Mental Health
  • General Anxiety Disorder Overview
  • General Anxiety Disorder - Dormant Projects

General Anxiety Disorder - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘General Anxiety Disorder - Pipeline Review, H2 2015’, provides an overview of the General Anxiety Disorder’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for General Anxiety...

  • Anxiety Disorder
  • Mental Health
  • United States
  • Product Initiative
  • H. Lundbeck A/S

Europe Anxiety Disorder Epidemiology and Patient Flow Analysis - 2017 ##.

  • Anxiety Disorder
  • Europe
  • France
  • Germany
  • Forecast
  • Anxiety Disorders - Discontinued Products
  • Anxiety Disorders - Dormant Projects

Anxiety Disorders - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Anxiety Disorders - Pipeline Review, H2 2016’, provides an overview of the Anxiety Disorders pipeline landscape. The report provides comprehensive information on the therapeutics under development for Anxiety Disorders, complete with...

  • Anxiety Disorder
  • Pharmaceutical
  • United States
  • Company
  • Product Initiative

Anxiety disorders and depression treatment market, 2014 - 2025 (USD Million) ##. ##. ## Canada ##. ##. ##. ## Canada anxiety disorders and depression treatment market, 2014 - 2025 (USD Million) ##. ## Europe ##. ##. ## Europe anxiety disorders and depression treatme

  • Antidepressant
  • Anxiety Disorder
  • Therapy
  • United States
  • Market Size
  • Anxiety Disorders Overview
  • Anxiety Disorders - Therapeutics Assessment

Anxiety Disorders - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Anxiety Disorders - Pipeline Review, H1 2016’, provides an overview of the Anxiety Disorders pipeline landscape. The report provides comprehensive information on the therapeutics under development for Anxiety Disorders, complete with...

  • Anxiety Disorder
  • Pharmaceutical
  • Research And Development
  • United States
  • Company Operations
  • 2.3 UPCOMING REPORTS
  • 4.1 BIBLIOGRAPHY

EpiCast Report: Generalized Anxiety Disorder - Epidemiology Forecast to 2024 Summary GAD is a common mental illness that is characterized by persistent and unrelenting worrying about everyday things such as personal finances, health, family, and work. GAD can be accompanied by one or all of the following physical symptoms:...

  • Anxiety Disorder
  • Germany
  • United States
  • World
  • Forecast
  • Global Anxiety Disorders Market
  • 06. Types of Anxiety Disorders

About Anxiety Disorders Anxiety is associated with uneasiness, fearfulness, and tension. Mild anxiety, for example, associated with exams or interview, is normal and triggers 'fight or flight' response. Anxiety without an identifiable cause, anxiety which persists even after the stressful condition is over, and anxiety which is out of proportion...

  • Anxiety Disorder
  • World
  • Eli Lilly & Co.
  • GlaxoSmithKline plc
  • Pfizer Inc.

General Anxiety Disorder - Pipeline Review, H## 2015 Table of Contents Table of Contents ## List of Tables ## List of Figures ## Introduction ## Global Markets Direct Report Coverage ## General Anxiety Disorder Overview ## Therapeutics Development ## Pipeline Products for

  • Anxiety Disorder
  • Mental Health
  • Therapy
  • World
  • Key clinical trial approval
  • 11.1 Factors impacting market growth

About Anxiety and Panic Disorders Drugs Anxiety is a normal reaction to stress, which helps to deal with tense situations. However, when anxiety becomes an excessive and irrational extension of everyday situations, it turns into disorder as per medical definition. Panic attacks, a type of anxiety disorder, are associated...

  • Anxiety Disorder
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • PIPELINE BY BIONOMICS LTD, H2 2018
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATIONS, H2 2018

Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Pipeline Review, H2 2018 Summary Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) pipeline Target constitutes close to 16 molecules. Out of which approximately 14 molecules are developed by companies and remaining by the universities/institutes....

  • Anxiety Disorder
  • United States
  • World
  • Product Initiative
  • Bionomics
  • Target
  • Target

Phobia Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Phobia Global Clinical Trials Review, H1, 2018" provides an overview of Phobia clinical trials scenario.This report provides top line data relating to the clinical trials on Phobia. Report includes...

  • Anxiety Disorder
  • Clinical Trial
  • Pharmaceutical
  • World
  • Product Initiative
  • Target
  • Clinical Trial profile. 60 Trial Title

Panic Disorders Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Panic Disorders Global Clinical Trials Review, H1, 2018" provides an overview of Panic Disorders clinical trials scenario.This report provides top line data relating to the clinical trials on Panic...

  • Anxiety Disorder
  • Pharmaceutical
  • World
  • Product Initiative
  • Pfizer Inc.
  • PIPELINE BY BIONOMICS LTD, H1 2018
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATIONS, H1 2018

Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Pipeline Review, H1 2018 Summary Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) pipeline Target constitutes close to 15 molecules. Out of which approximately 13 molecules are developed by companies and remaining by the universities/institutes....

  • Anxiety Disorder
  • Therapy
  • United States
  • Product Initiative
  • Bionomics
  • Clinical Trial profile. 13 Trial Title
  • Target

Agoraphobia Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Agoraphobia Global Clinical Trials Review, H1, 2017" provides an overview of Agoraphobia clinical trials scenario. This report provides top line data relating to the clinical trials on Agoraphobia. Report includes...

  • Anxiety Disorder
  • Hormone
  • World
  • Product Initiative
  • Torrent

The prominent features of this report are - ##.

  • Anxiety Disorder
  • Chronic Pain
  • Clinical Trial
  • Pharmaceutical
  • Eli Lilly & Co.

The prominent features of this report are - ##.

  • Anxiety Disorder
  • Chronic Pain
  • Clinical Trial
  • Pharmaceutical
  • Eli Lilly & Co.
  • PTSD THERAPEUTICS MARKET IN AMERICAS
  • MARKET DEFINITION

SSRIs are generally indicated for depression, panic disorder, social anxiety disorder/ social phobia, bulimia nervosa, obsessive-compulsive disorder (OCD), PTSD, generalized anxiety disorder, and premenstrual syndrome.

  • Anxiety Disorder
  • Eli Lilly & Co Ltd
  • GlaxoSmithKline plc
  • Lundbeck Inc.
  • Pfizer Inc.
  • Clinical Trial profile. 15 Trial Title
  • Target

Agoraphobia Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Agoraphobia Global Clinical Trials Review, H2, 2016" provides an overview of Agoraphobia clinical trials scenario. This report provides top line data relating to the clinical trials on Agoraphobia. Report includes an overview...

  • Anxiety Disorder
  • Hormone
  • Mental Health
  • World
  • Product Initiative
  • Clinical Trial profile. 153 Trial Title
  • Clinical Trial profile. 75 Trial Title

Post-Traumatic Stress Disorder (PTSD) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Post-Traumatic Stress Disorder (PTSD) Global Clinical Trials Review, H2, 2016" provides an overview of Post-Traumatic Stress Disorder (PTSD) clinical trials scenario. This report provides top line...

  • Anxiety Disorder
  • Clinical Trial
  • Therapy
  • World
  • Product Initiative
  • SYNTHETIC PEPTIDE TO TARGET NPSR FOR ANXIETY DISORDER - DRUG PROFILE
  • R&D Progress

Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2018, provides an overview of the Post-Traumatic Stress Disorder (PTSD) (Central...

  • Anxiety Disorder
  • Therapy
  • United States
  • Product Initiative
  • Tonix Pharmaceuticals Holding Corp.
  • HM-107 - DRUG PROFILE
  • BE FUNDED WITH A USD 12 MILLION PRIVATE PLACEMENT TO FOUR US INSTITUTIONAL INVESTORS.

Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2018, provides an overview of the Post-Traumatic Stress Disorder (PTSD) (Central...

  • Anxiety Disorder
  • Therapy
  • United States
  • Product Initiative
  • Tonix Pharmaceuticals Holding Corp.
  • Clinical Trial profile. 26 Trial Title
  • Clinical Trial profile. 34 Trial Title

Premenstrual Dysphoric Disorder (PMDD) Global Clinical Trials Review, H2, 2015 Summary GlobalData's clinical trial report, “Premenstrual Dysphoric Disorder (PMDD) Global Clinical Trials Review, H2, 2015" provides an overview of Premenstrual Dysphoric Disorder (PMDD) clinical trials scenario. This report provides top line...

  • Anxiety Disorder
  • Pharmaceutical
  • Therapy
  • World
  • Product Initiative
  • 09.1 MARKET OVERVIEW
  • 07.7 EPIDEMIOLOGY

About PTSD PTSD is a psychological condition that develops after a person is exposed to any traumatic event, and it drains a person emotionally. According to the DSM-IV codes found in the Diagnostic and Statistical Manual of Mental Disorders, published by the American Psychiatric Association (APA), PTSD is classified under anxiety disorders....

  • Anxiety Disorder
  • Azevan Pharmaceuticals, Inc.
  • GlaxoSmithKline plc
  • Otsuka Pharmaceutical Co., Ltd.
  • Pfizer Inc.